MedTrace Logo

Effects of Vitamin D3 and Prebiotics Supplementation on Cardiovascular Risk Factors in Patients With Type 2 Diabetes

NCT06351566 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2025-09-16

No results posted yet for this study

Summary

The goal of this randomized, double-blind, placebo-controlled, 6-month supplementation study in individuals with type 2 diabetes is to investigate whether taking daily dietary supplements of vitamin D3 (1600 IU) or prebiotics (inulin, 10 gram) has beneficial effects on cardiovascular disease risk factors.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

Vitamin D3

Vitamin D3 (cholecalciferol), 1600 IU per day.

DIETARY_SUPPLEMENT

Prebiotics

Prebiotics (inulin), 10g per day.

DIETARY_SUPPLEMENT

Vitamin D3 placebo

Vitamin D3 placebo

DIETARY_SUPPLEMENT

Prebiotics placebo

Prebiotics placebo, 10g per day.

Sponsors & Collaborators

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Gang Liu, PHD · School of Public Health, Tongji Medical College, Huazhong University of Science and Technology

  • An Pan, PHD · School of Public Health, Tongji Medical College, Huazhong University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-25
Primary Completion
2024-12-31
Completion
2025-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06351566 on ClinicalTrials.gov